Results 1 to 10 of about 278,477 (239)

Effect of fruit smoothie supplementation on psychological distress among people with substance use disorders receiving opioid agonist therapy: protocol for a randomised controlled trial (FruktBAR)

open access: yesBMC Nutrition, 2022
Background People with substance use disorders generally have unhealthy diets, including limited intake of fruit and vegetables. Evidence shows substantial health benefits from increasing fruit and vegetable consumption on various indicators and possibly
Lars T. Fadnes   +10 more
doaj   +1 more source

Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway

open access: yesScientific Reports, 2022
Chronic and harmful substance use is associated with a cluster of harms to health, including micronutrient deficiencies. Maintaining adequate levels of vitamin D is important for musculoskeletal and other aspects of health.
Mitra Bemanian   +6 more
doaj   +1 more source

Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)

open access: yesTrials, 2022
Background About 85% of patients receiving opioid agonist therapy (OAT) for opioid dependence are smoking tobacco. Although smoke-related pulmonary diseases are significant contributors to morbidity and mortality, few smoking cessation interventions are ...
Karl Trygve Druckrey-Fiskaaen   +7 more
doaj   +1 more source

Addictions

open access: yesRevue Médicale Suisse, 2019
New drugs available in a click, plethora of games, new regulations on cannabis, addiction medicine has a lot to do ! In 2018, Switzerland recognized a training certificate in addiction medicine, pathological gambling entered into ICD-11 and vaping, first considered with suspicion, found a place in the pharmacopoeia of the fight against tobacco.
Daeppen, Jean-Bernard   +8 more
openaire   +6 more sources

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

open access: yesBMC Psychiatry, 2020
Background Available evidence suggests that adjunctive treatment with immunomodulatory medications may be effective in the treatment of major depressive disorder (MDD).
Muhammad Ishrat Husain   +14 more
doaj   +1 more source

Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial

open access: yesTranslational Psychiatry, 2021
Patients with schizophrenia have exceedingly high rates of metabolic comorbidity including type 2 diabetes and lose 15–20 years of life due to cardiovascular diseases, with early accrual of cardiometabolic disease.
Sri Mahavir Agarwal   +15 more
doaj   +1 more source

Is smartphone addiction really an addiction? [PDF]

open access: yesJournal of Behavioral Addictions, 2018
Aims In light of the rise in research on technological addictions and smartphone addiction in particular, the aim of this paper was to review the relevant literature on the topic of smartphone addiction and determine whether this disorder exists or if it does not adequately satisfy the criteria for addiction.
Panova, Tayana, Carbonell, Xavier
openaire   +5 more sources

Equine-assisted services for individuals with substance use disorders: a scoping review

open access: yesSubstance Abuse Treatment, Prevention, and Policy, 2022
The implementation of equine-assisted services (EAS) during treatment for psychological disorders has been frequently documented; however, little is known about the effect of EAS on outcomes for populations with substance use disorder (SUD).
Liam Diaz   +6 more
doaj   +1 more source

Pleasure and Addiction [PDF]

open access: yesFrontiers in Psychiatry, 2013
What is the role and value of pleasure in addiction? Foddy and Savulescu (1) have claimed that substance use is just pleasure-oriented behavior. They describe addiction as "strong appetites toward pleasure" and argue that addicts suffer in significant part because of strong social and moral disapproval of lives dominated by pleasure seeking.
Matthews, Stephen   +2 more
openaire   +6 more sources

Addiction and will [PDF]

open access: yesFrontiers in Human Neuroscience, 2013
A hypothesis about the neurobiological bases of drive, drive reduction and will in addictive illness is presented. Drive reduction seems to require both SEEKING and gratification. Will is the everyday term for our experience of drives functioning within us. Addictive drugs take over the will by altering neurotransmission in the SEEKING system.
openaire   +3 more sources

Home - About - Disclaimer - Privacy

Warning: Invalid argument supplied for foreach() in /var/www/openaccess.click/sci_search.php on line 641